METROPOLISMetropolis Healthcare Limited
Healthcare · Diagnostics & Research · NSE · as of 2026-07-20 (delayed ~30 min in market hours)
₹573.75
▲ 5.22%Strong
Price & Volume
Loading chart…
Key Ratios
Market Cap (₹ cr)11,307.80
P/E59.27
P/B7.46
PEG0.81
ROE %13.37
ROCE %15.30
Debt / Equity0.15
EPS9.20
Revenue Growth %23.00
Profit Growth %73.00
Dividend Yield %0.37
Promoter Holding %48.86
FII Holding %44.99
DII Holding %—
Beta0.22
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
| Pullback to 21-EMA | LONG | 60% | ₹573.75 | ₹540.05 | ₹612.45 | 1.15 |
BUYConviction 87%
Why buy
- • Revenue growth: 23.0% YoY
- • Profit growth: 73.0% YoY
- • Debt/Equity: 0.15
- • RSI: 57
- • MACD: fresh bullish crossover
- • Price vs EMA21: above
- • Pullback to 21-EMA signal (setup quality 60%)
Bull case
- • Revenue growth: 23.0% YoY
- • Profit growth: 73.0% YoY
- • Debt/Equity: 0.15
- • RSI: 57
Bear case
- • Dividend yield: 0.37%
- • Trend strength (ADX): 16
- • Volume trend: 0.5x baseline
Key risks
- • Dividend yield: 0.37%
- • Trend strength (ADX): 16
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Entry (CMP)
₹573.75
Stop Loss
₹520.42
risk 9.3%
Target 1 (1.5R)
₹653.75
+13.9%
Target 2 (3R)
₹733.75
+27.9%
Support (20d)
₹516.25
Resistance (52w)
₹598.82
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹53.33/share
ATR (volatility)
₹21.33
avg daily range
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹21.33). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.
Score Breakdown
Fundamental
77
Technical
77
Momentum
77
Risk (safety)
69